JP2023535035A5 - - Google Patents

Info

Publication number
JP2023535035A5
JP2023535035A5 JP2023504356A JP2023504356A JP2023535035A5 JP 2023535035 A5 JP2023535035 A5 JP 2023535035A5 JP 2023504356 A JP2023504356 A JP 2023504356A JP 2023504356 A JP2023504356 A JP 2023504356A JP 2023535035 A5 JP2023535035 A5 JP 2023535035A5
Authority
JP
Japan
Prior art keywords
body weight
days
approximately
pharmaceutical composition
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023504356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535035A (ja
JP7803924B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/107575 external-priority patent/WO2022017412A1/zh
Publication of JP2023535035A publication Critical patent/JP2023535035A/ja
Publication of JP2023535035A5 publication Critical patent/JP2023535035A5/ja
Application granted granted Critical
Publication of JP7803924B2 publication Critical patent/JP7803924B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023504356A 2020-07-22 2021-07-21 造血幹細胞移植によって引き起こされる移植片対宿主病を治療する方法 Active JP7803924B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010713637 2020-07-22
CN202010713637.0 2020-07-22
PCT/CN2021/107575 WO2022017412A1 (zh) 2020-07-22 2021-07-21 治疗造血干细胞移植后的移植物抗宿主病的方法

Publications (3)

Publication Number Publication Date
JP2023535035A JP2023535035A (ja) 2023-08-15
JP2023535035A5 true JP2023535035A5 (cg-RX-API-DMAC7.html) 2024-07-29
JP7803924B2 JP7803924B2 (ja) 2026-01-21

Family

ID=79728482

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023504356A Active JP7803924B2 (ja) 2020-07-22 2021-07-21 造血幹細胞移植によって引き起こされる移植片対宿主病を治療する方法

Country Status (11)

Country Link
US (1) US12702668B2 (cg-RX-API-DMAC7.html)
EP (1) EP4186508A4 (cg-RX-API-DMAC7.html)
JP (1) JP7803924B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230043891A (cg-RX-API-DMAC7.html)
CN (2) CN116322670A (cg-RX-API-DMAC7.html)
AU (1) AU2021313124A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023001049A2 (cg-RX-API-DMAC7.html)
CA (1) CA3186564A1 (cg-RX-API-DMAC7.html)
IL (1) IL299985A (cg-RX-API-DMAC7.html)
TW (2) TW202216691A (cg-RX-API-DMAC7.html)
WO (1) WO2022017412A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3231781A1 (en) * 2021-09-18 2023-03-23 Beijing Tide Pharmaceutical Co., Ltd. Solid form of rho-associated protein kinase inhibitor or solvate thereof, preparation method and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011009568A (es) * 2009-03-09 2011-12-06 Surface Logix Inc Inhibidores de la rho cinasa.
RS63503B1 (sr) * 2012-10-05 2022-09-30 Kadmon Corporation Llc Inhibitori rho kinaze
EP3504204A4 (en) 2016-08-26 2020-05-27 Lycera Corporation INDAZOLYL-L, 2,4-THIADIAZOLAMINE AND RELATED COMPOUNDS FOR INHIBITING RHO-ASSOCIATED PROTEIN KINASES AND FOR TREATING DISEASES
WO2019000683A1 (zh) 2017-06-30 2019-01-03 北京泰德制药股份有限公司 Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
JP7311228B2 (ja) * 2017-06-30 2023-07-19 ベイジン タイド ファーマシューティカル カンパニー リミテッド Rho-関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用
US10329282B2 (en) * 2017-06-30 2019-06-25 Beijing Tide Pharmaceutical Co., Ltd. Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof
TWI818919B (zh) 2017-08-15 2023-10-21 美商歐米諾斯公司 用於治療和/ 或預防與造血幹細胞移植有關的移植物抗宿主病和/ 或瀰漫性肺泡出血和/ 或靜脈閉塞性病的方法

Similar Documents

Publication Publication Date Title
JP2022539329A5 (cg-RX-API-DMAC7.html)
JP2022522486A5 (cg-RX-API-DMAC7.html)
JP2020125355A (ja) 併用療法
JP2021147322A (ja) ステロイド系化合物及びその医薬用途
CN115190815A (zh) 芳基环己基胺衍生物及其在精神障碍的治疗中的用途
US11702427B2 (en) Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same
JP6218940B2 (ja) キニン系化合物、その光学異性体及びその製造方法と医薬用途
JP2012525437A5 (cg-RX-API-DMAC7.html)
TW201247613A (en) Ester derivatives of bimatoprost compositions and methods
JP2013519653A5 (cg-RX-API-DMAC7.html)
JP2011516511A5 (cg-RX-API-DMAC7.html)
WO2021060453A1 (ja) 架橋型光学活性2級アミン誘導体
JP7508620B2 (ja) ジヒドロクロメン誘導体
JP2017522304A5 (cg-RX-API-DMAC7.html)
TW202304914A (zh) 經取代之四環羧酸、其類似物及使用其之方法
JP2022531570A5 (cg-RX-API-DMAC7.html)
JP2022530890A5 (cg-RX-API-DMAC7.html)
JPH06211660A (ja) 神経成長因子産生促進剤
RU2013149416A (ru) Производные камптотецина, обладающие противоопухолевой активностью
CN117616019A (zh) 作为pcsk9抑制剂的新化合物
EP1674100A1 (en) Angiogenesis inhibitor
US20140309275A1 (en) Sphingosine Analogs, Compositions, and Methods Related Thereto
CN119080674A (zh) 作为pcsk9抑制剂的化合物
JP2006347942A (ja) βアミロイド生成抑制剤
JP2005298340A (ja) 疼痛治療薬